SCHEMBL9059243

SCHEMBL9059243

N=C(Nc1ccccc1-c1ccccc1)N1CCC(O)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ATM Q13315 1/20 0.46
CHRM3 P20309 9/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
TSHR P16473 3/20 0.45
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALOX12 P18054 1/20 0.42
GAA P10253 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
OPRK1 P41145 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059897 0.93 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9060408 0.92 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9059939 0.83 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9059607 0.83 CHRM3 (0.47) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9060090 0.82 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9059461 0.80 CHRM3 (0.54) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL6402476 0.80 LMNA (0.52) ALDH1A1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL9061351 0.80 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9059668 0.80 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AATMCHRM3
SCHEMBL9059673 0.80 CHRM3 (0.49) ALDH1A1MEN1KMT2AATMCHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed